Literature DB >> 22423128

Rhabdomyolysis in a patient treated with linezolid for extensively drug-resistant tuberculosis.

Matthew W Carroll1, Hongjo Choi, Seonyeong Min, Soohee Hwang, Hyeeun Park, Taeksun Song, Yumi Park, Han-Seung Jeon, Lisa C Goldfeder, Laura E Via, Janette Lebron, Boyoung Jin, Ying Cai, Clifton E Barry, Myungsun Lee.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22423128      PMCID： PMC3404720          DOI： 10.1093/cid/cis293

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  14 in total

1.  Clarithromycin significantly increases linezolid serum concentrations.

Authors:  Mathieu S Bolhuis; Richard van Altena; Donald R A Uges; Tjip S van der Werf; Jos G W Kosterink; Jan-Willem C Alffenaar
Journal:  Antimicrob Agents Chemother       Date:  2010-09-13       Impact factor: 5.191

2.  Serotonin syndrome precipitated by the monoamine oxidase inhibitor linezolid.

Authors:  Sharon Packer; Stephen A Berman
Journal:  Am J Psychiatry       Date:  2007-02       Impact factor: 18.112

3.  Inhibition of mammalian mitochondrial protein synthesis by oxazolidinones.

Authors:  E E McKee; M Ferguson; A T Bentley; T A Marks
Journal:  Antimicrob Agents Chemother       Date:  2006-06       Impact factor: 5.191

Review 4.  Antituberculosis drugs and hepatotoxicity.

Authors:  Wing Wai Yew; Chi Chiu Leung
Journal:  Respirology       Date:  2006-11       Impact factor: 6.424

5.  A method for estimating the probability of adverse drug reactions.

Authors:  C A Naranjo; U Busto; E M Sellers; P Sandor; I Ruiz; E A Roberts; E Janecek; C Domecq; D J Greenblatt
Journal:  Clin Pharmacol Ther       Date:  1981-08       Impact factor: 6.875

6.  Oxazolidinones inhibit cellular proliferation via inhibition of mitochondrial protein synthesis.

Authors:  Eva E Nagiec; Luping Wu; Steve M Swaney; John G Chosay; Daniel E Ross; Joan K Brieland; Karen L Leach
Journal:  Antimicrob Agents Chemother       Date:  2005-09       Impact factor: 5.191

Review 7.  Acute rhabdomyolysis associated with ofloxacin/levofloxacin therapy.

Authors:  Shu-Hwa Hsiao; Chia-Ming Chang; Chao-Jung Tsao; Yu-Yun J Lee; May-Ying Hsu; Ta-Jen Wu
Journal:  Ann Pharmacother       Date:  2004-11-23       Impact factor: 3.154

Review 8.  Mitochondrial fatty-acid oxidation disorders.

Authors:  Michelle Kompare; William B Rizzo
Journal:  Semin Pediatr Neurol       Date:  2008-09       Impact factor: 1.636

9.  Case series report of a linezolid-containing regimen for extensively drug-resistant tuberculosis.

Authors:  Rany Condos; Nicos Hadgiangelis; Eric Leibert; Germaine Jacquette; Timothy Harkin; William N Rom
Journal:  Chest       Date:  2008-07       Impact factor: 9.410

Review 10.  Mechanisms of zidovudine-induced mitochondrial toxicity and myopathy.

Authors:  Erin R Scruggs; Amie J Dirks Naylor
Journal:  Pharmacology       Date:  2008-05-27       Impact factor: 2.547
View more
  5 in total

1.  Linezolid for treatment of chronic extensively drug-resistant tuberculosis.

Authors:  Myungsun Lee; Jongseok Lee; Matthew W Carroll; Hongjo Choi; Seonyeong Min; Taeksun Song; Laura E Via; Lisa C Goldfeder; Eunhwa Kang; Boyoung Jin; Hyeeun Park; Hyunkyung Kwak; Hyunchul Kim; Han-Seung Jeon; Ina Jeong; Joon Sung Joh; Ray Y Chen; Kenneth N Olivier; Pamela A Shaw; Dean Follmann; Sun Dae Song; Jong-Koo Lee; Dukhyoung Lee; Cheon Tae Kim; Veronique Dartois; Seung-Kyu Park; Sang-Nae Cho; Clifton E Barry
Journal:  N Engl J Med       Date:  2012-10-18       Impact factor: 91.245

2.  Bactericidal activity and mechanism of action of AZD5847, a novel oxazolidinone for treatment of tuberculosis.

Authors:  V Balasubramanian; S Solapure; H Iyer; A Ghosh; S Sharma; P Kaur; R Deepthi; V Subbulakshmi; V Ramya; V Ramachandran; M Balganesh; L Wright; D Melnick; S L Butler; V K Sambandamurthy
Journal:  Antimicrob Agents Chemother       Date:  2013-11-04       Impact factor: 5.191

Review 3.  Potential factors involved in the causation of rhabdomyolysis following status asthmaticus.

Authors:  Hongmei Qiao; Huanji Cheng; Li Liu; Jianing Yin
Journal:  Allergy Asthma Clin Immunol       Date:  2016-08-22       Impact factor: 3.406

4.  Two cases of serious rhabdomyolysis during linezolid treatment.

Authors:  Arno M Lechner; Eva Past; Ulla Porsche; Jan M Kern; Uta Hoppe; Ingrid Pretsch
Journal:  Infection       Date:  2017-01-12       Impact factor: 3.553

5.  Rhabdomyolysis Associations with Antibiotics: A Pharmacovigilance Study of the FDA Adverse Event Reporting System (FAERS).

Authors:  Chengwen Teng; Courtney Baus; James P Wilson; Christopher R Frei
Journal:  Int J Med Sci       Date:  2019-10-15       Impact factor: 3.738
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.